Adverse effects in children after unintentional buprenorphine exposure

Ann-Jeannette Geib1, Kavita Babu, Michele Burns Ewald

  • 1Program in Medical Toxicology, Division of Emergency Medicine, Children's Hospital Boston, Boston, Massachusetts, USA. ajgeib@hotmail.com

Pediatrics
|October 4, 2006
PubMed

Insights

Unintentional buprenorphine exposure in toddlers caused severe respiratory and mental-status depression, requiring hospitalization. This highlights critical public health concerns for pediatric safety with increasing home-based buprenorphine use.

Area of Science:

  • Pediatric Toxicology
  • Emergency Medicine
  • Pharmacology

Background:

  • Buprenorphine, a partial opioid agonist, is increasingly used for opioid dependence treatment in the US.
  • Home-based therapy with buprenorphine raises potential risks for unintended exposures, particularly in children.

Observation:

  • A series of five toddlers experienced severe respiratory and mental-status depression following unintentional buprenorphine exposure.
  • Symptoms included significant central nervous system and respiratory compromise, necessitating intensive medical intervention.

Findings:

  • Despite buprenorphine's known ceiling effect on respiratory depression, all affected toddlers required hospital admission.
  • Standard urine toxicology screens were negative, delaying diagnosis; confirmatory testing was essential.
  • Opioid-antagonist therapy or mechanical ventilation was required for all cases, indicating severe toxicity.

Implications:

  • Unintentional pediatric buprenorphine exposure poses a significant public health risk.
  • Enhanced public awareness and safety protocols are crucial given the widespread use of buprenorphine.
  • Diagnostic challenges with routine toxicology screening necessitate heightened clinical suspicion and confirmatory testing.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...